Data / Form D filings / ABATTIS BIOCEUTICALS CORP
ABATTIS BIOCEUTICALS CORP: Form D filings
ABATTIS BIOCEUTICALS CORP, a health care company in Vancouver, British Columbia, Canada, filed 5 Form D notices with the SEC between 2011 and 2014. The latest, on April 14, 2014, reports $62,554 sold of a $62,554 offering to 1 investor.
Find out what ABATTIS BIOCEUTICALS CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- SUITE 1000 - 355 BURRARD STREET, Vancouver, British Columbia, Canada, V6C 2
- Phone
- (604) 538-6650
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1515768
The full lists. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2014 | New notice | $62,554 | $62,554 | $0 | 1 | Apr 1, 2014 | sec.gov |
| Apr 3, 2014 | New notice | $2,489,145 | $83,709 | $2,405,436 | 6 | Mar 18, 2014 | sec.gov |
| Mar 21, 2012 | New notice | $20,014 | $20,014 | $0 | 1 | Mar 7, 2012 | sec.gov |
| Apr 6, 2011 | Amendment | $29,727 | $29,727 | $0 | 3 | Nov 3, 2010 | sec.gov |
| Mar 17, 2011 | New notice | $297,265 | $297,265 | $0 | 3 | Nov 3, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mike Withrow | Executive Officer, Director | |
| Robert J. Hedley | Director | |
| Rene J. David | Executive Officer | |
| Tim Fealey | Director | |
| Douglas J. Sorocco | Director |
Every Form D from the week of Apr 14, 2014 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what ABATTIS BIOCEUTICALS CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.